Report Detail
Global Oral Vaccine Market Insights, Forecast to 2025
- RnM3402100 |
- 03 August, 2020 |
- Global |
- 146 Pages |
- QYResearch |
- Pharma & Healthcare
Oral Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Vaccine market is segmented into
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others
Segment by Application, the Oral Vaccine market is segmented into
Public
Private
Regional and Country-level Analysis
The Oral Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Vaccine Market Share Analysis
Oral Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Vaccine business, the date to enter into the Oral Vaccine market, Oral Vaccine product introduction, recent developments, etc.
The major vendors covered:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
1 Study Coverage
- 1.1 Oral Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Oral Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oral Vaccine Market Size Growth Rate by Type
- 1.4.2 Rotavirus Vaccine
- 1.4.3 Cholera Vaccine
- 1.4.4 Oral Polio Vaccine
- 1.4.5 Others
- 1.5 Market by Application
- 1.5.1 Global Oral Vaccine Market Size Growth Rate by Application
- 1.5.2 Public
- 1.5.3 Private
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oral Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Oral Vaccine Revenue 2015-2026
- 2.1.2 Global Oral Vaccine Sales 2015-2026
- 2.2 Global Oral Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Oral Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Oral Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Vaccine Competitor Landscape by Players
- 3.1 Oral Vaccine Sales by Manufacturers
- 3.1.1 Oral Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Oral Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Oral Vaccine Revenue by Manufacturers
- 3.2.1 Oral Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Oral Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oral Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oral Vaccine Revenue in 2019
- 3.2.5 Global Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Oral Vaccine Price by Manufacturers
- 3.4 Oral Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Oral Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oral Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Oral Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Oral Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Oral Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Oral Vaccine Revenue by Type (2015-2020)
- 4.1.3 Oral Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oral Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oral Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oral Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Oral Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oral Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Oral Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Oral Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Oral Vaccine Revenue by Application (2015-2020)
- 5.1.3 Oral Vaccine Price by Application (2015-2020)
- 5.2 Oral Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oral Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oral Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oral Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Oral Vaccine by Country
- 6.1.1 North America Oral Vaccine Sales by Country
- 6.1.2 North America Oral Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Oral Vaccine Market Facts & Figures by Type
- 6.3 North America Oral Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Oral Vaccine by Country
- 7.1.1 Europe Oral Vaccine Sales by Country
- 7.1.2 Europe Oral Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oral Vaccine Market Facts & Figures by Type
- 7.3 Europe Oral Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Oral Vaccine by Region
- 8.1.1 Asia Pacific Oral Vaccine Sales by Region
- 8.1.2 Asia Pacific Oral Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Oral Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Oral Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Oral Vaccine by Country
- 9.1.1 Latin America Oral Vaccine Sales by Country
- 9.1.2 Latin America Oral Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Oral Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Oral Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oral Vaccine by Country
- 10.1.1 Middle East and Africa Oral Vaccine Sales by Country
- 10.1.2 Middle East and Africa Oral Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Oral Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Oral Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Oral Vaccine Products Offered
- 11.1.5 Merck Related Developments
- 11.2 GSK
- 11.2.1 GSK Corporation Information
- 11.2.2 GSK Description and Business Overview
- 11.2.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 GSK Oral Vaccine Products Offered
- 11.2.5 GSK Related Developments
- 11.3 Sanofi
- 11.3.1 Sanofi Corporation Information
- 11.3.2 Sanofi Description and Business Overview
- 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sanofi Oral Vaccine Products Offered
- 11.3.5 Sanofi Related Developments
- 11.4 Lanzhou Institute
- 11.4.1 Lanzhou Institute Corporation Information
- 11.4.2 Lanzhou Institute Description and Business Overview
- 11.4.3 Lanzhou Institute Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Lanzhou Institute Oral Vaccine Products Offered
- 11.4.5 Lanzhou Institute Related Developments
- 11.5 Serum Institute
- 11.5.1 Serum Institute Corporation Information
- 11.5.2 Serum Institute Description and Business Overview
- 11.5.3 Serum Institute Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Serum Institute Oral Vaccine Products Offered
- 11.5.5 Serum Institute Related Developments
- 11.6 Valneva
- 11.6.1 Valneva Corporation Information
- 11.6.2 Valneva Description and Business Overview
- 11.6.3 Valneva Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Valneva Oral Vaccine Products Offered
- 11.6.5 Valneva Related Developments
- 11.7 Shanghai United Cell
- 11.7.1 Shanghai United Cell Corporation Information
- 11.7.2 Shanghai United Cell Description and Business Overview
- 11.7.3 Shanghai United Cell Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Shanghai United Cell Oral Vaccine Products Offered
- 11.7.5 Shanghai United Cell Related Developments
- 11.8 Bibcol
- 11.8.1 Bibcol Corporation Information
- 11.8.2 Bibcol Description and Business Overview
- 11.8.3 Bibcol Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Bibcol Oral Vaccine Products Offered
- 11.8.5 Bibcol Related Developments
- 11.9 PaxVax
- 11.9.1 PaxVax Corporation Information
- 11.9.2 PaxVax Description and Business Overview
- 11.9.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 PaxVax Oral Vaccine Products Offered
- 11.9.5 PaxVax Related Developments
- 11.10 Vabiotech
- 11.10.1 Vabiotech Corporation Information
- 11.10.2 Vabiotech Description and Business Overview
- 11.10.3 Vabiotech Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Vabiotech Oral Vaccine Products Offered
- 11.10.5 Vabiotech Related Developments
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Oral Vaccine Products Offered
- 11.1.5 Merck Related Developments
- 11.12 EuBiologics
- 11.12.1 EuBiologics Corporation Information
- 11.12.2 EuBiologics Description and Business Overview
- 11.12.3 EuBiologics Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 EuBiologics Products Offered
- 11.12.5 EuBiologics Related Developments
- 11.13 Panacea Biotec Ltd
- 11.13.1 Panacea Biotec Ltd Corporation Information
- 11.13.2 Panacea Biotec Ltd Description and Business Overview
- 11.13.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Panacea Biotec Ltd Products Offered
- 11.13.5 Panacea Biotec Ltd Related Developments
- 11.14 Bio-Med
- 11.14.1 Bio-Med Corporation Information
- 11.14.2 Bio-Med Description and Business Overview
- 11.14.3 Bio-Med Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Bio-Med Products Offered
- 11.14.5 Bio-Med Related Developments
- 11.15 Halfkin Bio-Pharmaceuticals
- 11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
- 11.15.2 Halfkin Bio-Pharmaceuticals Description and Business Overview
- 11.15.3 Halfkin Bio-Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Halfkin Bio-Pharmaceuticals Products Offered
- 11.15.5 Halfkin Bio-Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Oral Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Oral Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Oral Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Oral Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Oral Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Oral Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Oral Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Oral Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Oral Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Oral Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Oral Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Oral Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Oral Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Oral Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Oral Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Oral Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Oral Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Oral Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Oral Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Oral Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Oral Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Oral Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Oral Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Oral Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oral Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oral Vaccine . Industry analysis & Market Report on Oral Vaccine is a syndicated market report, published as Global Oral Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Oral Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
